XML 86 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment and Geographic Information
 9 Months Ended
Jan. 23, 2015
Segment Reporting [Abstract]  
Segment and Geographic Information
Segment and Geographic Information
Segment information
The Company’s management evaluates performance and allocates resources based on profit and loss from operations before income taxes and interest expense, net, not including special (gains) charges, restructuring (credits) charges, net, certain litigation charges, net, and acquisition-related items. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended April 25, 2014.
The Company operates under three reportable segments and three operating segments. The Company's Cardiac and Vascular Group consists of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The primary products sold by this operating segment include those for cardiac rhythm disorders and cardiovascular disease. The Company's Restorative Therapies Group consists of three divisions: Spine, Neuromodulation, and Surgical Technologies. The primary products sold by this operating segment include those for spinal conditions and musculoskeletal trauma, neurological disorders, urological and digestive disorders, and ear, nose, and throat conditions. The primary products sold by the Company's Diabetes Group include those for diabetes management.
Net sales of the Company’s reportable segments include end-customer revenues from the sale of products they each develop and manufacture or distribute. Net sales and earnings before income taxes by reportable segment are as follows:
 
Three months ended
 
Nine months ended
(in millions)
January 23,
2015
 
January 24,
2014
 
January 23,
2015
 
January 24,
2014
Cardiac and Vascular Group
$
2,224

 
$
2,119

 
$
6,765

 
$
6,478

Restorative Therapies Group
1,645

 
1,608

 
4,897

 
4,764

Diabetes Group
449

 
436

 
1,295

 
1,198

Total Net Sales
$
4,318

 
$
4,163

 
$
12,957

 
$
12,440


 
Three months ended
 
Nine months ended
(in millions)
January 23,
2015
 
January 24,
2014
 
January 23,
2015
 
January 24,
2014
Cardiac and Vascular Group
$
722

 
$
663

 
$
2,148

 
$
2,177

Restorative Therapies Group
482

 
454

 
1,318

 
1,318

Diabetes Group
144

 
128

 
381

 
310

Total Reportable Segments’ Earnings Before Income Taxes
1,348

 
1,245

 
3,847

 
3,805

Special (gains) charges
138

 
—

 
38

 
(40
)
Restructuring charges, net
—

 
15

 
(30
)
 
(3
)
Certain litigation charges, net
—

 
—

 
—

 
(24
)
Acquisition-related items
(80
)
 
(200
)
 
(182
)
 
(104
)
Interest expense, net
(81
)
 
(25
)
 
(94
)
 
(98
)
Corporate
(131
)
 
(80
)
 
(280
)
 
(312
)
Earnings Before Income Taxes
$
1,194

 
$
955

 
$
3,299

 
$
3,224


Geographic information
Net sales to external customers by geography are as follows:
 
Three months ended
 
Nine months ended
(in millions)
January 23,
2015
 
January 24,
2014
 
January 23,
2015
 
January 24,
2014
United States
$
2,459

 
$
2,273

 
$
7,248

 
$
6,817

Europe and Canada
1,019

 
1,058

 
3,135

 
3,138

Asia-Pacific
630

 
642

 
1,934

 
1,931

Other Foreign
210

 
190

 
640

 
554

Total Net Sales
$
4,318

 
$
4,163

 
$
12,957

 
$
12,440


Certain prior period net sales to external customers by geography have been corrected to conform to the current period classification. These revisions are considered immaterial.